The goal of this project is to evaluate a set of potential quality metrics for their utility in monitoring quality across the pharmaceutical manufacturing sector.
This project aids to support FDA's efforts in transforming quality oversight from a qualitative to a quantitative and expertise-based
assessment in order to assure that quality drugs are available to the American public.
The outcomes of the project could also be used to assist in the development of a risk-based inspection approach for domestic and foreign drug establishments.